Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24366937

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Feb 1
First author
Vergote IB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Aug 1;32(22):2388. doi: 10.1200/JCO.2014.56.2785.
    note
    Source null
    related pmid
    24982455
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 Aug 1;32(22):2387-8. doi: 10.1200/JCO.2014.55.3016.
    note
    Source null
    related pmid
    24982465
    relationship
    Comment in

Authors and identifiers

  1. name
    Vergote IB
    type
    Author
  2. name
    Jimeno A
    type
    Author
  3. name
    Joly F
    type
    Author
  4. name
    Katsaros D
    type
    Author
  5. name
    Coens C
    type
    Author
  6. name
    Despierre E
    type
    Author
  7. name
    Marth C
    type
    Author
  8. name
    Hall M
    type
    Author
  9. name
    Steer CB
    type
    Author
  10. name
    Colombo N
    type
    Author
  11. name
    Lesoin A
    type
    Author
  12. name
    Casado A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Vergote IB
    type
    Author
  2. name
    Jimeno A
    type
    Author
  3. name
    Joly F
    type
    Author
  4. name
    Katsaros D
    type
    Author
  5. name
    Coens C
    type
    Author
  6. name
    Despierre E
    type
    Author
  7. name
    Marth C
    type
    Author
  8. name
    Hall M
    type
    Author
  9. name
    Steer CB
    type
    Author
  10. name
    Colombo N
    type
    Author
  11. name
    Lesoin A
    type
    Author
  12. name
    Casado A
    type
    Author
bibliography ids
  1. nci-bib-e5cc654a272734f98cc5f34f
book metadata
content sha256
ac893933bd231d4374cd4a31ad1683b9e07331d01cb685852800d2b4485697d5
document type
citation
dois
  1. 10.1200/JCO.2013.50.5669
electronic publication date
display
2013 Dec 23
precision
day
year
2013
evidence scope
bibliographic_metadata_only
id
pubmed:24366937
immutable id
pubmed:24366937@ac893933bd231d4374cd4a31ad1683b9e07331d01cb685852800d2b4485697d5
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
4
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
320-6
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Aug 1;32(22):2388. doi: 10.1200/JCO.2014.56.2785.
    note
    Source null
    related pmid
    24982455
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2014 Aug 1;32(22):2387-8. doi: 10.1200/JCO.2014.55.3016.
    note
    Source null
    related pmid
    24982465
    relationship
    Comment in
outcomes validated
false
pmid
24366937
provenance
batch id
af10498814d931b53231
provider
NCBI PubMed ESummary
record sha256
6296ef51ea408c3005e73bcd6559701fc34c1ef0b84bb50b5656da685b65e364
response sha256
077a09272afe77e74d5ff01cb33335ddb8a638b7afbafb70ec20e837a0c85c7f
retrieved at
2026-09-09T23:47:00.193465+00:00
publication date
display
2014 Feb 1
precision
day
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24366937/
title
Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup study.

Preserved source evidence · Not medical advice